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1. KURZZUSAMMENFASSUNG 
 
 
1.2. Ziel 
 
Ziel der Arbeit ist die Darstellung und funktionelle Charakterisierung von T-T Zell 
Interaktionen während der Differenzierung von naïven CD4+ T Helfer Zellen in vivo. 
Dabei sollen die Interaktionen von naïven CD4+ T Helfer Zellen mit differenzierten T 
Helfer Zellen Typ 2 (TH2) mittels Messung spezifischer T Helfer (TH) Zytokine 
dargestellt werden.  
 
 
1.3. Methoden 
 
T Zell-homing naïver CD4+ und TH2 T Zellen – spezifisch für Influenza-
Hämagglutinin(HA)- oder Ovalbumin(OVA)-Peptid - in drainierende Lymphknoten 
wurde nach Immunisierung und subkutanem Peptidstimulus bei naïven BALB/c 
Empfänger-Mäusen in vivo untersucht.  
Zur Darstellung der ’homing’ Kapazität wurden Methoden der Durchflußzytometrie 
(FACS) und Immunfluoreszenz verwendet. Die Messung der einzelnen T-Zell 
Zytokine wurde unter Verwendung von Enzyme-Linked-Immunosorbent-Assays 
(ELISA) und Enzyme-Linked-Immunospot(ELISPOT) Analysemethoden zur Messung 
von Interferon(IFN)-γ sowie CT.4S-Assay und ELISPOT zur IL-4 Analyse 
durchgeführt.  
 
 
1.4. Ergebnisse 
 
Es konnte gezeigt werden, dass sich nach in vivo Stimulation mit dem jeweiligen 
Peptid und Complete Freund’s Adjuvant (CFA) eine annährend gleiche Anzahl naïver 
T Zellen und TH2 Zellen in den drainierenden Lymphknoten wiederfanden und sich in 
unmittelbarer Nachbarschaft in der parakortikalen T-Zell Zone darstellten.  
Mit dieser Versuchsanordnung konnten TH2 Zellen die CFA vermittelte TH1 Induktion 
bei naïven T-Zellen verhindern und eine Differenzierung in TH2 Zellen bewirken. 
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Dabei vermittelten die TH2 Zellen die TH2-Induktion bei naïven T Zellen nur, wenn 
beide –naïve T Zellen und TH2 Zellen– zeitgleich und im gleichen Lymphknoten mit 
dem jeweiligen Peptid aktiviert wurden. Hingegen konnten TH2 Zellen von IL-4-
negativen Mäusen eine CFA-vermittelte TH1 Induktion nicht verhindern. Somit zeigte 
sich, dass eine TH2-Induktion bei naïven T-Zellen stets IL-4 von TH2 Zellen unter 
gleichzeitiger Aktivierung beider T Zell Subpopulationen bedarf.  
 
 
1.4. Zusammenfassung 
 
Bei der Differenzierung naïver T Zellen in einen TH2 Phänotyp spielen zahlreiche 
Signale eine wichtige Rolle. IL-4 ist dabei einer der wichtigsten Faktoren für die 
Differenzierung von naïven T Zellen in einen TH2 Phänotyp. Es konnte gezeigt 
werden, dass direkte, IL-4-vermittelte, T-T-Zell Interaktionen stattfinden und dass 
unter bestimmten Bedingungen IL-4 von differenzierten TH2 Zellen eine wichtige 
Rolle in der TH Zell Differenzierung in vivo einnimmt. 
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2. ABSTRACT 
 
 
2.1. Purpose 
 
To define the T-T cell interactions during differentiation of naïve CD4+ T helper cells 
in vivo displaying the interactions of naïve CD4+ and differentiated type 2 (TH2) T 
helper cells by measuring specific T helper (TH) cytokines. 
 
 
2.2. Methods 
 
The homing capacity of naïve T cells bearing a T cell receptor (TCR) specific for 
influenza hemagglutinin (HA) or TH2 cells bearing a TCR specific for ovalbumin 
(OVA) was analyzed in draining lymph nodes of naïve murine BALB/c recipients after 
immunization and peptide challenge in vivo.  
T cell homing was visualized by flow cytometry (FACS) and fluorescence microscopy. 
For measuring different T cell specific cytokines we used established systems as 
Enzyme-Linked-Immunosorbent Assay (ELISA) and Enzyme-Linked-Immunospot-
(ELISPOT) Assay for interferon(IFN)-γ and CT.4S assay and ELISPOT for IL-4 
analysis.  
 
 
2.3. Results 
 
We showed that naïve and TH2 cells migrate with similar dynamics into draining 
lymph nodes and were found in close vicinity in T cell areas, when driven by antigen 
in complete Freunds’ adjuvant (CFA). Under these conditions, TH2 cells prevented 
CFA-mediated TH1-induction and deviated the differentiation of naïve TH cells toward 
a TH2 phenotype. OVA- TH2 cells induced TH2-differentiation in naïve T cells 
exclusively, if naïve and TH2 memory cells were both activated simultaneously in the 
same lymph node.  
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‘TH2’-cells from IL-4-/- mice were unable to affect CFA-mediated TH1-induction 
showing that TH2-derived IL-4 was strictly required to deviate naïve HA TH cells 
toward a TH2 phenotype. 
 
 
2.4. Conclusions 
 
Among the various signals capable of promoting TH2 differentiation IL-4 is one of the 
most important factor for differentiation of naïve T cells into TH2 phenotype. Direct, IL-
4-mediated, T-T cell interactions could be measured and demonstrated that TH2 
derived IL-4 under restricted conditions plays a major role in TH cell differentiation in 
vivo.  
 8
3. INTRODUCTION 
 
 
After engagement of the T-cell receptor (TCR) by the appropriate peptide MHC 
complex, which triggers clonal expansion, helper T (TH) cells rapidly undergo 
programmed differentiation. This differentiation process can result in highly polarized 
immune responses in the case of chronic infections, such as parasitic infections. A 
more heterogenous response is often shown by allergies or acute immune responses 
(Abbas and Sher 1996). This heterogeneity of immune responses was presented with 
strikingly different and polarized clinical and pathological features. 
In general, the regulation of immune response upon antigenic stimulus is dependent 
on a variety of different cells and accessory signals. The different pathways of 
immune responses are determined by the antigen itself and its way of presentation 
to different cell types. To eliminate antigens specifically, antigen-presenting cells 
(APC) offer these proteins after phagocytosis and antigen-processing either to CD8+ 
cytotoxic T cells (CTL) or regulatory CD4+ T helper cells. Multiple accessory signals, 
such as soluble mediators, hormons and cytokines, are additionally required in 
regulation of cellular immunity.  
Thereby, CD4+ T helper cells play a critical role in immune regulation steering 
immune responses in different pathways. Naïve CD4+ T cells differentiate during 
initial priming by dendritic antigen presenting cells (DC) into distinct phenotypes that 
differ by the spectrum of cytokines they produce upon re-stimulation. The two most 
discernible populations of CD4+ T lymphocytes are T helper cells type 1 (TH1) and T 
helper cells type 2 (TH2), where TH1 clones produce interferon- γ (IFN-γ), 
interleukin(IL)-2 and tumor-necrosis factor(TNF)-β, and TH2 clones IL-4, IL-5, IL-6 
and IL-13 (Fig.1). 
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Fig. 1 CD4+ T cell differentiation after antigen stimulus.  
TH1 and TH2 T cell differentiation, secreted cytokine profiles and inflammatory responses (modified to 
Mosmann et al., 1986). 
 
 
Studies of autoimmune diseases and infectious diseases demonstrated that the 
cytokine pattern of CD4+ memory T cells ultimately determines their biological 
function. Interferon γ (IFN-γ) producing TH1 cells are responsible for cell-mediated 
immunity, whereas interleukin 4 (IL-4) TH2 cells are responsible for extracellular 
immunity. TH1 cells establish delayed type hypersensitivity responses (DTHR) that 
provide solid protection against intracellular pathogens, such as Leishmania species 
and Toxoplasma gondii, but may become harmful when directed against 
autoantigens expressed by solid organs (Abbas and Sher 1996, Paul and Seder 
1994, Rocken and Shevach 1996). On the other side IL-4 producing TH2 cells 
promote production of non-complement binding immunoglobulin such as IgE 
protecting against extracellular pathogens and promoting TH2 responses to multiple 
aero-allergens, which are involved in allergic asthma (Urban and Schreiber 1994, 
Kay 2001).  
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The process by which an uncommitted TH cell develops into a mature TH1 or TH2 cell 
is highly plastic (Murphy and Reiner 2002). During the process of T cell stimulation 
(Rocken and Hauser 1992) T cells are influenced by a large spectrum of different 
signals, such as TCR-ligand interaction (Tsitoura and Lamb 1996, Constant and 
Bottomly 1997), the functional phenotype of the stimulating DC (Moser and Murphy 
2000, Rissoan and Liu 1999, Langenkamp and Sallusto 2000, Biedermann and 
Rocken 2001), co-stimulatory signals (Rodriguez-Palmero and Hunig 1999, Bennett 
and Heath 1998, Ridge and Matzinger 1998), various soluble mediators such as 
prostaglandins (Snijdewint and Kapsenberg 1993) or corticosteroids (Ramirez and 
Mason 1996), and by cytokines (Paul and Seder 1994, Diehl and Rincon 2002, 
Trinchieri 1995). 
The cytokines IL-12 and IL-4, acting through signal transducer and activator of 
transcription 4 (STAT4) and STAT6, respectively, are key determinants of the 
outcome. It has been proposed also that antigen dose, co-stimulators, genetic 
modifiers and other non-cytokine factors have crucial roles in determining the 
dominance of a TH cell response. Many data indicate that certain crucial transcription 
factors play causal roles in the gene-expression programmes of TH1 and TH2 cells. 
For example the zinc-finger transcritpion factor GATA3 seems to be crucial for 
inducing some important attributes, as genes encoding for IL-4, IL-13 and IL-5 
(Szabo 2000, Ouyang 1998+2000, Zheng and Flavell 1997). 
Although all these factors may influence the determination of lymphokine-producing 
phenotype, the effects appear to be secondary to the dominant role of the 
lymphokines and cytokines during early stimulus. The two strongest signals on TH 
cell differentiation are IL-4, which induces TH2 cells, and IL-12 mainly produced by 
activated macrophages and dendritic cells, which induces TH1 differentiation (Abbas 
and Sher 1996, Rocken and Shevach 1996, O’Garra 1998). 
Some of these signals, such as IL-6 or IL-12, can be directly be provided by the 
stimulating DC (Paul and Seder 1994, Langenkamp and Sallusto 2000, Diehl and 
Rincon 2002, Trinchieri 1995). IL-2, a major cytokine for TH cell activation, itself 
appears to be required for naïve cells to develop into TH1- or TH2-like cells but is not 
deterministic of their differentiation fate.  
As the TH1 and TH2 subpopulations interact and cross-regulate each other, the 
development of IFN-γ producing cells is strikingly inhibited by IL-4. INF- γ producing 
TH1 cells amplify TH1 development and inhibits proliferation of TH2 cells, whereas  
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IL-10 produced by TH2 cells blocks activation of TH1 cells. Understanding these 
regulatory pathways, a conceptual problem raised. IL-4 is required for TH2 
differentiation, but is only produced by T cells after their differentiation into TH2 
effector cells (Racke and Rocken 1994). Therefore IL-4 must be provided by third 
party cells. Mast cells, basophils (Yoshimoto and Paul 1994) and especially NK T 
cells (Bendelac and Roak 1997, Lanouis and Louis 1997) are important in vivo-
sources of IL-4. Some studies provided strong evidence that early IL-4 producing NK 
T cells play a central role in the instruction of TH2 responses and may be involved in 
the protection against TH1-mediated autoimmune diseases (Bendelac and Roak 
1997, Lanouis and Louis 1997). In sharp contrast, the role of IL-4-producing TH2 
cells on the differentiation of freshly primed CD4+ T cells remains enigmatic.  
Studies on infectious diseases such as leishmania major (L. major) in BALB/c mice 
showed that early IL-4 producing CD4+ T cells are essential for the TH2 
differentiation of co-stimulated ‘by-stander’ T cells (Schmitz and Radbruch 1994).  
However, these findings did not show whether this differentiation relies on T-T cell 
interaction or on early effects of the developing TH2 cells on DC modifying DC 
functions.  
Substantial evidence suggests the central role of T cell-derived IL-4 on surrounding 
T cells can modulate the T cell differentiation of a naïve population, especially if their 
respective antigens are presented on the same DC (Schuhbauer and Mueller2000) 
and T cell differentiation relies primarily on differentiation status of antigen 
presenting cells (Rissoan and Liu 1999, Stetson and Locksley 2002, Racke and 
Rocken 1994). 
In this study we analyzed the interaction between naïve CD4+ T cells expressing a T 
cell receptor (TCR) specific for influenza hemagglutinin (HA) and primed TH2 cells, 
bearing a TCR specific for ovalbumin (OVA) after stimulation in the presence of 
complete Freunds’ adjuvant, which induces TH1 differentiation. When re-stimulated 
in vivo by the specific peptide, naïve CD4+ T cells and TH2 cells enriched inside T 
cell areas of draining lymph nodes with identical dynamics and bound to the same 
DC. Under these conditions, activated TH2 cells overcome the TH1-inducing capacity 
of CFA and deviated the differentiation of the freshly activated CD4+ T cells from a 
TH1 toward a TH2 phenotype. This deviation strictly required activation of the TH2 
cells by specific peptide, close temporal and physical vicinity of naïve and TH2 
memory cells and TH2 cell-derived IL-4, which directly shows that TH2 cell-derived 
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IL-4 can instruct surrounding TH cells to develop a TH2 phenotype. Such contagious 
TH2-induction may be of central relevance for the consecutive spreading of TH2 
responses to multiple protein-antigens in allergic asthma or allergic rhinitis 
(Biedermann and Rocken 2001). 
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4. METHODS 
 
 
4.1. Reagents and antibodies 
Highly purified murine recombinant (r) IL-4 was purchased from Strathmann 
(Hamburg, Germany), 1 μg corresponding to 2 x 106 U and IL-2 of Chiron 
Therapeutics (Ratingen, Germany). Anti-CD4 (L3T4), anti-CD8 (Ly-2) and anti-B220 
(CD45R) microbeads were from Miltenyi Biotech (Bergisch-Gladbach, Germany) and 
soluble CD4 mAb (Gk1.5) and CD8 mAb (5367.2) were hybridoma supernatants 
(ATCC, Manassas, VA). HA-peptide (H-SFERFEIFPK-OH) and OVA-peptide (H-
ISQAVHAAHAEINEAGR-OH) were from Biotrend (Cologne, Germany). Mouse cells 
were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM, Biochrom, 
Berlin, Germany) supplemented with 5% heat inactivated fetal calf serum, L-
glutamine (216 mg/ml), penicillin, streptomycin (all from Life Technologies, Karlsruhe, 
Germany), 10 mM HEPES, and 5 x 10-5 M 2-mercaptoethanol (Merck, Darmstadt, 
Germany).  
For FACS analysis we used biotin-labelled mAb recognizing the idiotype for the HA-
TCR (mAb 6.5, Lanoue and Sarukhan 1997), FITC-labelled mAb KJ1.26 recognizing 
OVA-TCR cells, was purchased from Caltag (Burlingame, CA). SA-Cy5 blue 
fluorescent avidin was from Caltag, rat anti-mouse CD4 mAb (GK1.5), PE- or FITC-
labelled, and mAbs for immunohistology, ELISA and ELISPOT analysis were from 
PharMingen (Hamburg, Germany). PKH-26 red-fluorescent and PKH-67 green 
fluorescent dyes were from Sigma-Aldrich (Munich, Germany). 
 
 
4.2. Mice 
BALB/c mice were purchased from either Harlan-Winkelmann (Borchen, Germany) or 
Harlan Olac Ltd. (Bicester, UK). DO11.10 mice transgenic for the OVA-peptide 
specific TCR and BALB/cxIL-4-/- mice (Kopf and Solbach 1996) were originally from 
Max Plank Institute Freiburg (Germany), transgenic BALB/c mice carrying an I-Ed-
restricted TCR specific for the HA 110-119 peptide (Prescott and Sly 1999) from 
Basel Institute of Immunology (Basel, Switzerland). Mice were maintained under 
pathogen-free conditions in isolator cages in the animal facility of the Department of 
Experimental Surgery, Ludwig-Maximilians-University. 
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4.3. Cell culture 
CD4+ T cells were isolated from lymph nodes harvested and sorted using MACS 
magnetic beads (Miltenyi Biotec) according to the manufacture’s protocol and 90-
98% CD4+ T cells were stimulated for three days in 96 well flat bottom tissue culture 
plates with APC (T-depleted spleen cells, prepared by incubating total spleen cells 
first with CD4 and CD8 mAb and subsequently with complement, Dade Behring, 
Marburg, Germany), 1,000 U ml-1 rIL-4 and 0.3 µM OVA-peptide and further 
expanded with IL-2 (50 IU ml-1). Cells were re-stimulated once weekly. In all 
experiments, APC were derived from BALB/cxIL-4-/- mice. ‘IL-4-/- – TH2 cells’ were 
generated by priming BALB/cxIL-4-/- mice with OVA dissolved in incomplete Freunds’ 
adjuvant and OVA-peptide. Subsequently, CD4+ T cells were purified and expanded 
as above.  For ex vivo analysis, CD4+ T cells were isolated from draining lymph 
nodes by MACS-sorting and 105 sorted cells were stimulated for 48 hours with either 
medium alone, HA-peptide (7.5 μM) or OVA-peptide (0.3 μM) and 106 IL-4-/--APC in 
200 μl medium. 
 
 
4.4. In vivo experiments 
Polarized OVA-TCR TH2 cells (5x106) and 5x106 freshly isolated, naïve HA-TCR cells 
were intraperitoneally transferred into naïve, 6-8 weeks old BALB/c mice on day -4. 
On day 0, mice were challenged subcutaneously into the right and left flanks with HA- 
or OVA-peptide (100µg ml-1) dissolved in CFA (DIFCO, Kansas City, MO) on day 4 
after adoptive transfer. T cells from draining nodes and control nodes were analyzed 
at the time indicated.  
 
 
4.5. FACS analysis and immunhistology 
At the indicated time, draining lymph nodes were harvested, cells counted and T cells 
were quantified by FACS analysis using a FACScan cytometer (Becton Dickinson, 
Heidelberg, Germany). For immunohistology T cells were stained prior to injection 
with PKH-red (OVA-TCR) or PKH-green (HA-TCR) and lymph nodes were isolated at 
the indicated time after priming. Cryo-sections of draining lymph nodes were stained 
and analyzed using immunfluorescent microscopy (Leitz, Wetzlar, Germany).  
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4.6. Proliferation and cytokine assays 
For proliferation analysis T cells (0.1x106 well-1) were cultured in round-bottomed 
Maxi Sorp surface microplates (Nunc-Gibco, Wiesbaden, Germany). After 48 hours 
[3H] thymidine (1 μCi well-1) was added and plates were harvested 8 hours later. For 
cytokine assays T cells (1.0x106 well-1) were cultured in 96 flat-bottomed well plates 
and supernatants were harvested for cytokine analysis after 48 hours. IFN-γ was 
assayed by ELISA (PharMingen, Hamburg, Germany) and IL-4 using the CT.4S cell 
line (Hu-Li and Paul 1989), with a detection limit at 10 U ml-1.  
For ELISPOT analysis we coated 96 round-bottomed plates (Multiscreen-Millipore, 
Schwalbach, Germany) with mAb rat anti-mouse IFN-γ (4 μg ml-1) or 11B11 IL-4 mAb 
(5 μg ml-1). T cells (0.5x106 well-1) and irradiated APC (0,5x106 well-1) were cultured 
with 0.3 μM OVA- or 7.5 μM HA-peptide and 5 U ml-1 IL-2 for 48 hours. Cytokine 
producing T cells were stained with secondary mAb and the number of cells was 
analysed by ELISPOT-Reader (Biosys, Karben, Germany). 
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5. RESULTS 
 
 
5.1. Migration-dynamics and localization of naïve CD4+ T cells and TH2 
memory cells in draining lymph nodes 
 
To investigate potential interactions between naïve CD4+ T cells and TH2 cells we 
installed different experimental groups and studied migration dynamics of these two 
distinct populations in draining lymph nodes. CD4+ T cells specific for either influenza 
hemagglutinin antigen (HA) or ovalbumin antigen (OVA) peptide were derived from 
naïve TCR-transgenic BALB/c mice (Fig.2). 
 
 
 
Fig.2. Experimental protocol and groups to test T–T cell interactions. 
(A) In vitro generation of OVA-TCR transgenic TH2 cells and chronologic treatment of BALB/c 
recipients. Cells were injected intra-peritoneally (day -4) and mice were challenged on day 0 with 
either HA-, OVA-peptide or both. Analysis of draining LN after 2-12 d by FACS, immunhistology and 
cytokine assays. 
(B) Installing experimental groups to indicate T-T cell interactions. Naïve group received only PBS 
injections, group III and IV were controls for activity of injected TH cells. 
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Primarily we analyzed the migration dynamics of these two distinct populations in 
draining lymph nodes.  
We primed OVA-TCR cells for one week in vitro with antigen presenting cells (APC), 
OVA peptide and IL-4, and re-stimulated cells 3-4 times in the presence of IL-4 in 
order to establish stable TH2 cell lines (Seder and Fazekas de St Groth 1992, Swain 
1994). 
After in vitro T cell peptide priming under polarizing conditions, about 98% of the 
OVA-specific TH2 cells expressed the transgenic TCR and the cells acquired regular 
cytokine profiles, whereas naïve cells showed very low amounts of cytokines. Upon 
re-stimulation with peptide and APC, 4x105 cells T cells proliferated and released 
more than 6000 U/ml IL-4 and no detectable IFN-γ (<30 ngml-1, Fig.3). 
 
 
 
Fig.3. In vitro proliferation and cytokine release of OVA-TH2 cells. 
(A) After in vitro generation of OVA-TCR TH1 and TH2 cells proliferation of either DO11.10 OVA-TCR 
transgenic naïve TH cells (black histograms) or restimulated OVA-TCR transgenic TH2 cells (gray 
histograms) is shown. 
(B) IL-4 (black histograms) or IFN-γ (gray histograms) secretion by the referring cell lines. Data 
showing one of 6 experiments, negative controls (unstimulated cells) showed either cytokine secretion 
under detection limit. Background values are subtracted. cpm-counts per minute; DL, detection limit. 
 
 
One critical condition in the experimental model was that naïve and in vitro-polarized 
T cell populations should home in sufficient numbers into draining lymph nodes when 
reintroduced in vivo and that they retain their characteristic cytokine pattern when re-
stimulated.  
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Therefore we installed different experimental groups, varying in injected T cell types 
and in vivo peptide stimulus. The first two groups received naïve HA-transgenic T 
cells (group I) with one or both peptides simultaneously (HA- and OVA-peptide, 
group II). Control groups III and IV were immunized with one of the transgenic T cells 
and challenged with both peptides. Naïve group received only PBS injections (Fig. 
2B). 
 
To illustrate whether polarized OVA TH2 and naïve HA-transgenic T cells home into 
draining lymph nodes with similar dynamics and in sufficient numbers, we injected 
5x106 OVA-TCR TH2 cells together with 5x106 freshly isolated naïve HA-TCR 
transgenic T cells from 6.5 HA-transgenic mice intra-peritoneally to naïve BALB/c 
recipients (day -4, Fig. 2A).  
Four days later (day 0), we primed the mice with either OVA peptide, HA peptide or 
both peptides (100 µg ml-1) emulsified in CFA subcutaneously into the right and left 
flank (Fig. 2). Investigating the migration of each of the transgenic T cell populations 
into draining or distant lymph nodes we daily analyzed axillar or inguinal lymph nodes 
by FACS. 
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Fig. 4. Naïve HA-TCR cells and OVA-TCR TH2 cells migrate with similar dynamics into draining 
lymph nodes. 
Between day 3 and 5 injected OVA- and HA-TCR TH cells accumulated in draining lymph nodes. 
FACS analysis in group II after cell harvesting, staining either with 6.5-Biotin-Streptavidin-PE and 
CD4-FITC for HA-TCR transgenic or with CD4-PE and KJ1.26-FITC for OVA-TCR transgenic TH cells. 
In multiple experiments frequency of OVA-TCR and HA-TCR cells varied between 2 and 4% of total T 
cells in draining lymph nodes. Both transgenic TH cells were found in similar amounts in draining 
lymph nodes. 
(A) Relative HA-TCR TH cells and (B) OVA-TCR TH2 cell frequency in groups I-IV; memory TH2 cells 
migrated only when activated by referring peptide in draining lymph node (group I and II). 
 
 
Measuring the quantity of transgenic T cells, naïve HA-TCR cells constituted about 
0,4% of all lymph node CD4+ T cells on day of priming. Following injection of 
complete Freunds’ adjuvant (CFA), HA-TCR cells neither accumulated in draining 
lymph nodes. After priming with CFA and specific HA-peptide their frequency 
increased up to 10-fold in draining nodes, peaking between days 3 and 5 at 2-6% of 
total CD4+ T cells (Fig. 4A). Similar migration we observed in injected OVA-TCR TH2 
cells. They migrated into axillar lymph nodes and, after in vivo-priming, became 
enriched to the same extend as naïve HA-TCR TH cells (Fig. 4B). In multiple 
experiments the frequency of either OVA-TCR cells or HA-TCR cells varied between 
2% and 4% of total CD4+ T cells. Importantly, only when specific peptide was 
emulsified in CFA OVA-specific CD4+KJ6.5+ were attracted into the  
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lymph nodes (Fig. 4), underlining that both naïve and memory cells migrate and 
proliferate only when specific peptide is present. The finding that naïve HA-TCR cells 
and OVA-TCR TH2 cells migrated with similar dynamics into draining nodes when 
activated by peptide in CFA also implies that the two cell populations did not 
compete for space. 
Further we investigated the morphology of draining lymph nodes on analysis day 
using cryo-sections of axillary lymph nodes and analyzing by immunfluorescence 
microscopy. Prior to injection OVA-TCR TH2 stained with PKH26-red and HA-TCR TH 
cells with PKH67-green fluorescent antibody before adoptive transfer. About 85-94% 
of transgenic T cells were stained and transferred intraperitoneally into naïve BALB/c 
recipients. In vivo we stimulated both populations with peptide in CFA referring 
experimental protocol group II. Draining lymph node cells were analyzed between 
day 4-6 after peptide challenge. Thus, naïve HA-TCR cells and OVA-TCR TH2 cells 
accumulated in the same paracortical T cell areas and both cell types were observed 
in close vicinity at day 4-6 after in vivo challenge (Fig. 5). In the absence of specific 
peptide neither naïve nor TH2 cells enriched inside paracortical T cell areas. These 
observations suggest that inside the paracortical T cell area the two T cell 
populations were activated in close vicinity and communicate either direct or 
indirectly using a common dendritic cell (DC). 
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Fig.5. Localization of CD4+ HA T cells (green and OVA TH2 cells (red) in draining lymph nodes. 
Prior to injection OVA-TCR TH2 cells were stained with PKH26 red-fluorescent antibody and HA-TCR 
T cells with PKH67 green-fluorescent antibody before adoptive transfer. (A) Cells were analyzed by 
FACS before and after intraperitoneal injection and in vivo stimulation with referring peptides in CFA. 
(B) Cryo-sections of draining lymph nodes were analysed by fluorescence microscopy. Transferred T 
cells were found in close vicinity in paracortical T cell area. 
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The following analysis step was to investigate the homing dynamics of the two 
transgenic T cells. Therefore the number of HA-CD4+ and OVA-TCR TH2 cells in 
draining lymph nodes was quantified during the first week of T cell stimulation with 
peptide in CFA. Both transgenic T cells peaked between day 4-6 after peptide 
challenge and were present in sufficient numbers (Fig. 6 A, B). In former 
experiments others have shown that in the absence of additional in vivo stimulation, 
TH2 and naïve CD4+ T cells home differently into surrounding lymph nodes. In sharp 
contrast, when stimulated by peptide in CFA, naïve HA-TCR cells and OVA-TCR TH2 
cells homed in our experiments with same dynamics and expanded to similar extent 
in draining lymph nodes.  
Besides the morphological vicinity of injected T cells these findings underlined that 
naïve HA-TCR cells and OVA-TCR TH2 cells migrated with similar dynamics into 
draining lymph nodes using potential T cell attractants. 
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Fig. 6. Time course analysis and quantification of HA-CD4+ cells and OVA-TH2 cells in draining 
lymph nodes during the first week of T cell stimulation with peptide in CFA, control groups received 
PBS only. (A) Relative and (B) absolute numbers of T cells detected in draining lymph node using 
FACS analysis. (C) Time course analysis of cytokines (IL-4 and IFN-γ) secreted by HA TCR 
transgenic T cells primed in vivo either in presence (solid line, group II) or absence (dotted line, group 
I) of OVA-TCR TH2 cells. Stimulation protocol see methods, each data point reflects mean ± standard 
deviation from 2-4 independent experiments. Negative controls (unstimulated cells) were either 
cytokine negative or, if not, background values were subtracted. 
 
 
 
 
 
 
 
 
 
 
 
 
 24
5.2. Functional in vivo interaction between naïve CD4+ T cells and  
TH2 memory cells  
 
As OVA-TCR TH2 cells and naïve HA-TCR CD4+ T cells migrated with similar 
dynamics into draining lymph nodes and co-localized in close vicinity in the 
paracortical lymph node area, we asked whether IL-4 secreted by activated TH2 cells 
could potentially influence the differentiation of naïve CD4+ T cells during initial 
priming. Therefore we first activated naïve HA-TCR CD4+ T cells with HA peptide in 
CFA and isolated these T cells after priming at different times to determine their 
cytokine phenotype (Fig. 2). Between days 5 and 6, CD4+ T cells were isolated from 
draining lymph nodes and stimulated for cytokine release. We incubated for ex vivo 
experiments 1 x 106 negatively selected CD4+ T cells in vitro with 7.5 µM HA- or 0,3 
µM OVA-peptide and 1 x 106 BALB/c x IL-4-/- APC. Each data point reflects mean ± 
standard deviations of cytokine secretion from 2-4 independent experiments (Fig. 6 
B, C). 
As expected, priming HA-TCR CD4+ T cells with HA-peptide dissolved in CFA 
induced within 4 days HA-specific TH1 cells that produced large amounts of IFN-γ but 
no or only very little IL-4 upon in vitro stimulation. Cytokine producing capacity 
peaked between days 5 and 7 and rapidly declined thereafter (Fig. 6 C, dotted line). 
T cells produced no cytokine in the absence of peptide and underlined hereby the 
specifity of peptide activation.  
 
Importantly, during priming with HA peptide in CFA, HA-TCR cells differentiated into 
TH1 cells whether resting OVA-TH2 cells were present or not (Fig. 7 A, group I and 
III). Even though OVA-TCR TH2 cells were present in draining lymph nodes (Fig. 3 
B, group I), resting TH2 cells did not affect CFA-driven TH1 development in HA-TCR 
cells (Fig. 7 A, group I versus group III). But when we dissolved HA and OVA peptide 
in CFA and activated simultaneously memory OVA-TCR TH2 cells and naïve HA-
TCR in the same lymph node, HA-TCR developed a strongly polarized TH2 
phenotype, even in the presence of CFA, which normally drives CD4+ T cells into TH1 
phenotype direction (Fig. 7 A, group II). This effect was specific for OVA-TCR TH2 
cells, because naïve OVA-specific CD4+ T cells did not affect CFA-mediated TH2 
induction in HA-TCR cells (Fig. 7 A, group III). Cytokine production was specific, as 
T cells produced no detectable cytokine in the absence of peptide (fig.7 A, naïve 
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group). 
To underline the role of activated TH2 cells for naïve T cell differentiation we tested 
secreted cytokines in all experimental groups. Therefore BALB/c mice received 
intraperitoneally naïve HA-TCR TH cells together with or without OVA-TCR TH2 cells 
and groups I–IV were primed (Fig. 1b). Between days 5 and 6, CD4+ T cells were 
isolated from draining lymph nodes and stimulated for cytokine release. We 
incubated for ex vivo stimulation 1,0x106 TH cells + 1,0x106 BALB/cxIL-4-/- APC and 
7,5 µM HA- or 0,3 µM OVA-peptide. In CT.4S assay serial dilutions of supernatants 
were compared to those elicted by known amounts of murine rIL-4 as standards 
(5x103 CT.4S cells/well; incubation for 48h and thymidin staining). For ELISPOT 
analysis, incubation of 0,4x106 TH cells with 0,8x106 APC from IL-4 deficient mice, IL-
2 and referring peptides for 48h and visualization by ELISPOT-reader. 
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Fig. 7. TH2 cell-derived IL-4 deviates CFA-driven TH1 differentiation towards a TH2 phenotype. 
BALB/c mice received intraperitoneally naïve HA-TCR TH cells together with or without OVA-TCR TH2 
cells and groups I-IV were primed according to the protocol outlined in Fig.2B. (A) Analysis of 
secreted cytokines by ELISA for IFN-γ and CT.4S bioassay for IL-4 production in supernatants. Cells 
were harvested between day 5 and 6 and re-stimulated for 48 h. In CT.4S assay serial dilutions of 
supernatants were compared to those elicted by known amounts of murine rIL-4 as standards (5x10³ 
CT.4S cells/well; incubated for 48h and thymidin staining). (B) For ELISPOT analysis, incubation of 
0,4x106 TH cells with 0,8x106 APC from IL-4 deficient mice (IL-4-/-), IL-2 and referring peptides for 48h 
and visualized by ELISPOT reader. Data show one representative out of five experiments. HA-
reactive cells (black histograms), OVA-reactive cells (dashed histograms). Ratio of IFN-γ or IL-4 
producing cells were 12,3 in group I and 0,4 in group II. Wells were photographed by ELISPOT 
reader™. Dot-forming unit=cytokine producing HA-TCR T cells. 
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Whether we determined cytokine-release in the supernatant upon re-stimulation 
(Fig.7A, groups I and II) or the frequency of cytokine producing T cells using 
ELISPOT analysis (Fig. 7 B, groups I and II), simultaneous stimulation of OVA-TCR 
TH2 cells with the naïve HA-TCR strongly reduced the IFN-γ-production and 
increased the amount of IL-4 by HA-TCR cells. In the supernatant, IFN-γ-release 
decreased about 10-30 fold while IL-4-release increased 10-30 fold, diminishing the 
IFN-γ : IL-4-ratio 100-1,000-fold. ELISPOT analysis provided equivalent results, as 
the ratio of IFN-γ+ : IL-4+ cells switched by a factor of 30 (12.3 in group I and 0.4 in 
group II, Fig. 7 A). Thus, simultaneous activation of naïve HA-TCR CD4+ T cells 
together with OVA-TCR TH2 cells entirely overruled the TH1-inducing signals 
provided by CFA and deviated the freshly activated CD4+ T cells towards a TH2 
phenotype (Fig. 6, 7 A, B).  
Time-course analysis revealed that OVA-TCR TH2 cells affected not only HA-specific 
T cell differentiation but also accelerated the appearance of HA-specific T cell 
responses (Fig. 6), with a stable reversal of the IFN-γ : IL-4-ratio over the entire 
period when transgenic T cells were enriched in the nodes (Fig. 6). 
 
 
5.3. TH2 cell-derived IL-4 induces a TH 2 phenotype in naïve CD4+ T cells 
 
The data above showed that OVA-TCR TH2 cells prevented TH1 differentiation of 
CFA-stimulated, naïve HA-TCR T cells and deviated their development toward a TH2 
phenotype. As IL-4 is the strongest single factor capable of deviating T cell 
differentiation toward a TH2 phenotype, it was likely that the IL-4 derived from OVA-
TCR TH2 cells directly induced differentiation of the HA-TCR TH2 phenotype. 
Alternatively, OVA-TCR TH2 cells might have influenced the surrounding 
environment, especially by causing the DC to acquire a TH2-inducing phenotype 
(Moser and Murphy 2000, Rissoan and Liu 1999, Langenkamp and Sallusto 2000, 
Liu and Gilliet 2001). Even though this is unlikely, as IL-4 itself primes DC 
(Biedermann and Rocken 2001, Hochrein and Shortman 2000, Kalinski and 
Kapsenberg 1999) directly, we could not exclude the possibility that other unknown 
TH2 cell-associated factors induced maturation of a TH2-differentiating DC2-
phenotype.  
To address the role of TH2-derived IL-4 in the deviation of HA-TCR cells from a TH1- 
 28
toward a TH2-phenotype, we generated OVA-specific ‘TH2’ cell lines from IL-4-/- mice. 
We developed these lines by immunizing IL-4- deficient BALB/c mice (IL-4-/-) with 
OVA in incomplete Freunds’ adjuvant (IFA). Subsequently we stimulated and 
expanded CD4+ T cells from draining lymph nodes with APC, OVA-peptide, IL-2 and 
IL-4 in vitro (Seder and Fazekas de St Groth 1992). 
These T cell lines proliferated normally in response to OVA peptide but produced 
neither IL-4 nor IFN-γ (Fig. 8 A, B). Functional analysis of CD4+ T cells revealed that 
these OVA-specific T cells migrated with similar dynamics to draining lymph nodes as 
OVA-TCR TH2 cells, since CD4+ T cells from draining lymph nodes proliferated 
vigorously in response to OVA peptide. No difference was seen, whether peptide-
specific T cells originated from a transgenic animal or whether from T cell lines 
established by repetitive in vitro stimulation (Fig. 8 C).  
 29
 
 
Fig. 8. OVA- TH2 cells providing IL-4 in a paracrine fashion deviate surrounding naïve TH cells 
towards a TH2 phenotype. In vitro generation of IL-4 deficient ‘OVA-TCR TH2’ cells from BALB/c x 
IL4-/- mice. (A) After repetitive stimulation, proliferation of IL-4-deficient and non-deficient T cell 
cultures by thymidin assay and (B) cytokine secretion of IL-4-/-, DO11.10 IL-4+/+ and TH1 in vitro 
cultures was measured by ELISA and CT.4S assays. IL-4 deficient OVA-TCR TH2 cells and naïve HA-
TCR TH cells were injected, 4 days later challenged and harvested on day 3-5 after peptide challenge. 
(C) Ex vivo proliferation and (D) cytokine secretion were tested by ELISA and ELISPOT assays. HA-
reactive cells (black histograms), OVA-reactive cells (dashed histograms). Untreated mice or mice 
primed with HA peptide in CFA alone were positive and negative controls. One out of two similar 
experiments is shown; cpm-counts per minute, DL-detection limit. 
 
 
Subsequently we injected OVA-‘IL-4-/- TH2 cells’ together with naïve HA-TCR cells 
intraperitoneally and primed mice to the protocol of group II (Fig. 2 B). On day 6 we 
isolated CD4+ T cells from draining lymph nodes and stimulated cells with either 
medium, HA- or OVA peptide either for proliferation or cytokine production into the 
supernatant. While IL-4-producing OVA-TCR TH2 cells from IL-4-producing BALB/c 
(IL-4+/+) strongly promoted TH2-differentiation of HA-TCR cells (Fig. 8 D), IL-4-
deficient ‘OVA- TH2’ cells were not capable of affecting CFA-driven TH1 development 
of HA-specific CD4+ T cells (Fig. 8 D). As OVA- TH2 cells from IL-4-/- mice did not 
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differ from OVA-TCR TH2 cells, except from their capacity to produce IL-4, the data 
underline the central role of TH2 cell-derived IL-4 in deviating the surrounding HA-
TCR cells from a CFA-driven TH1 development toward a TH2 phenotype. 
 
 
5.4. Deviation of the CFA-driven TH1-development toward a TH2-phenotype 
requires co-localization of OVA-TH2 and naïve CD4+ T cells  
 
As mentioned above TH2 cells can deviate CFA-driven TH1-development of naïve 
CD4+ T cells toward a TH2-phenotype, but only if TH2 cells were able to release IL-4 
and if both T cell populations were activated simultaneously. As in vivo activation of 
naïve and TH2 cells occurred in close vicinity in the paracortical region in draining 
lymph nodes (Fig. 5), it was likely that the IL-4 secreted by activated OVA-TCR TH2 
cells deviated the expanding HA-TCR T cells toward a TH2-phenotype. To test the 
requirement for physical co-localization, we first injected both naïve and TH2 cell lines 
intraperitoneally. During the subsequent immunization we then separated these two 
T cell populations in vivo by injecting the OVA-CFA suspension (50 µg ml-1 OVA-
peptide) into the right flank and the HA-CFA suspension (50 µg ml-1 HA-peptide) into 
the left flank. On day 6 we isolated CD4+ T cells separately from the right and the left 
axillary lymph nodes. FACS analysis confirmed that OVA-TCR TH2 cells migrated 
preferentially into draining lymph nodes of the right axilla, while HA-TCR cells 
enriched primarily in draining nodes of the left axilla and functional analysis revealed 
these results (Fig. 9). 
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Fig. 9. Deviation toward a TH2 phenotype requires co-localization of OVA-TH2 and naïve HA-
TCR cells. Challenge with HA- and OVA-peptide in separated flanks of BALB/c mice (according to 
group II in experimental protocol) 4 days after intraperitoneal injection of OVA-TCR TH2 and HA-TCR 
TH cells. (A) In vitro-proliferation in response to each peptide separately for the right and the left 
axillary lymph nodes, IL-4 and IFN-γ production in response to medium, HA or OVA peptide 
separately for CD4+ T cells from left (B) or right (C) axillary lymph nodes. Controls were CD4+ T cells 
from unprimed mice or mice treated according to protocol group I or III (Fig. 2 B). Negative controls of 
unstimulated cells were either cytokine-negative or, if not, background values were subtracted, cpm-
counts per minute. 
 
 
T cells from the right axillar node proliferated strongly in response to OVA-peptide 
(Fig. 9a) and expressed a typically TH2 pattern (Fig. 9b). Importantly, the few HA-
TCR cells that migrated to this right axillar node (Fig. 9a) also developed a TH2-
phenotype (Fig. 9c). 
Thus, TH2 cells can indeed instruct the surrounding naïve T cells to differentiate 
toward a TH2 phenotype exclusively if both populations, the naïve CD4+ T cells and 
the TH2 cells are activated simultaneously and inside the same lymph node. 
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6. DISCUSSION 
 
T cell differentiation, a crucial step in immune responses, is the result of complex 
cellular and molecular regulation. After activation, CD4+ helper T cells differentiate 
into TH1 or TH2 effector cells, which specialize in producing distinct cytokines to 
mediate different types of immune responses (Paul and Seder 1994). TH cell 
activation and differentiation is an essential step of T-dependent immune responses.  
Prior investigations have revealed a complex regulation of the TH differentiation 
program, which includes T cell receptor (TCR) and costimulatory receptor signals, 
polarizing cytokines, lineage-specific transcriptional factors and signal transduction 
pathways (Contant and Bottomly 1997, Glimcher and Murphy 2000). For example, 
STAT6 induced expression of TH2 specific lineage factors and enhances TH2 
differentiation (Takeda and Akira 1996, Kaplan and Grusby 1996 and Shimoda and 
Ihle 1996). 
In this study we introduced an in vivo model of interactions between CD4+ T cells of 
different specificity polarized towards TH1 or TH2 type and demonstrated that naïve 
and TH2 memory T cells can co-migrate with indistinguishable dynamics into draining 
lymph nodes, home to the paracortical T cell area and are located in close vicinity 
when activated by specific peptide antigen. Although previous studies have 
emphasized that effector memory T cells are hindered in their ability to home to 
lymph nodes (Iezzi and Lanzavecchia 2001). Because naïve TH cells and primed TH2 
cells express different sets of chemokine receptors, their migration dynamics might 
be different. Thus, others have shown that in the absence of additional in vivo 
stimulation, TH2 memory cells or naïve CD4+ T cells home differently into the 
surrounding lymph nodes, we established that polarized T cells did reach lymph 
nodes in adequate numbers after transfer intraperitoneally. 
The finding that naïve HA-TCR cells and OVA-TCR TH2 cells migrated with similar 
dynamics into draining nodes when activated by peptide in CFA also implies that the 
two cell populations did not compete for space. In sharp contrast, when stimulated by 
peptide in CFA, naïve HA-TCR cells and OVA-TCR TH2 cells arrived with the same 
dynamics and expanded to the same extent in the draining node. TH2 cell-derived IL-
4 was obligatory to turn over CFA-driven TH1 development and deviated the 
differentiation of naïve T cells from a TH1- toward a TH2-phenotype. Moreover these 
results argue that under certain sets of conditions, naïve CD4+ T cells can be 
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stimulated down the TH2 pathway through autocrine IL-4. Campbell et al (Campbell 
and Kelso 2001) have reported similar experiments in which they examined the 
capacity of CD4+ T cells with a naïve phenotype to give rise to IL-4-producing clones 
in the presence or absence of added IL-4 when stimulated. Others argue that IL-4 
induces a new program of gene activation that results in the TH2 phenotype and a 
molecular basis is discussed for an IL-4-mediated selective growth advantage on TH2 
cells (Noben-Trauth and Paul 2002). 
Under these conditions, TH2 cell-derived IL-4 directly abrogated CFA-driven TH1 
development and deviated the differentiation of naïve T cells from a TH1- toward a 
TH2-phenotype. When primed under the influence of TH2 cell-derived IL-4, the ratio 
of IFN-γ- : IL-4-producing cells changed 30-fold within HA-specific T cell population, 
showing that this concomitant stimulation of naïve and TH2 cells affected not only the 
ratio of cytokine production (100- to 1,000-fold), but also the number of cytokine-
releasing cells. The critical dependence on TH2 cell-derived IL-4 and on the close 
physical association of naïve and TH2 cells strongly argues that the effect was 
directly mediated by T-T cell interactions and not due to an indirect modification of 
the DC phenotype (Chitnis and Khoury 2004). 
In addition, multiple “three-cell type” clusters of T cell interaction have been postulated 
(Kalinski and Kapsenberg 1999, Tucker and Bretscher 1982, Mitchison and O’Malley 1987). 
Strong evidence for such interactions came from in vitro and in vivo data suggesting that 
paracrine production of IL-2 by ‘T helper’ cells might be required for efficient generation of 
cytotoxic T cells, especially conditions where TCR-ligand interactions are low (Kurts and 
Miller 1997). More recent data questioned the concept of direct T-T cell interactions as it 
could be shown that T cell help for the induction of cytotoxic T cell responses relies on the 
priming of DC through CD40-CD40L-mediated signal exchange between DC and TH1 cells 
rather than on paracrine IL-2 production by T helper cells (Schoenberger and Melief 1998, 
Bennett and Heath 1998, Ridge and Matzinger 1998). Others mentioned that antigen dose, 
type of antigen-presenting cell and time of differentiation can contribute to T cell 
differentiation (Rothoeft and Schauer 2003). 
Further investigations demonstrated that in allergic individuals an irregular proportion 
of T regulatory 1-like cells mediating multiple suppressive mechanisms in healthy 
individuals and allergy-inducing TH2 cells may be decisive in the development of 
allergy (Akdis 2004). Alternatively, polarized effector T cells might modulate 
successive immune responses via modulation of DC function. An elegant study by 
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Alpan (2004) demonstrated that antigen-specific CD4+ T effector cells could influence 
the CD4+ T cell differentiation directed against an unrelated antigen by modulating 
DC function, but only if antigens were presented by the same DCs. This DC-
modulating capacity of activated CD4+ T cells is IL-4 and IL-10 dependent, possibly 
explaining why - in a TH2-adoptive transfer model of asthma - TH2 priming to an 
unrelated novel inhaled antigen is dependent on IL-4 produced by the transferred TH2 
cells (Alpan and Matzinger 2004, De Heer and Lambrecht 2004). Dendritic cells have 
functions not only in the induction of allergic TH2 responses but also during the 
effector response as it occurs in clinical asthma. From a therapeutic perspective, the 
capacity of DCs to stimulate the expansion and function of antigen-specific regulatory 
and type 2 helper T cells might be exploited to treat allergic disease and could lead to 
the design of better prevention or therapeutic strategies for asthma (Lambrecht and 
Pauwels 1998). 
Similarly, two competing concepts are established for the development of TH1 or TH2 
responses in humans and rodents. As IL-4 delivery during T cell stimulation allows to deviate 
the development of TH1-responses in an antigen-specific mode (Kurts and Miller 1997, 
Rocken and Shevach 1994) and seems to be the strongest single signal capable of inducing 
IL-4-producing T cells also in vivo (Rocken and Shevach 1996, O’Garra 1998). It is likely that 
‘paracrine’ delivery of IL-4 is also important for the development of IL-4-producing TH2 cells. 
Despite this strong evidence for a critical role of IL-4 in the development of TH2 cells, the 
physiological source and the significance of IL-4 during the development of TH2-responses 
remaines enigmatic. Mast cells, basophils and, especially, NK T cells are potential sources 
of IL-4 that might promote TH2 differentiation of naïve T cells (Voehringer and Locksley 
2004). 
Elegant studies provided strong evidence that early IL-4-producing NK T cells play a 
central role in the instruction of TH2 responses and may be involved in the protection 
against TH1-mediated autoimmune diseases. The role of ‘paracrine’ delivered IL-4 
was especially investigated in NK T cells, as these cells produce IL-4 very rapidly 
during early T cell priming (Yoshimoto and Paul 1994). The absence of IL-4-
producing NK T cells has been associated with aberrant development of TH1-
responses even favor the development of TH1-mediated autoimmune disease 
(Bendelac and Roak 1997). These data, suggesting a central role for NK T cell-
derived IL-4 in the development of TH2 responses, are in conflict with showing that 
highly purified naïve CD4+ T cells can normally acquire a TH2 phenotype, even in the 
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environment of IL-4-/- mice (Schmitz and Radbruch 1994) and others which unraveled 
the normal development of TH2-responses in L. major-infected BALB/c mice, even in 
the absence of NK T cells (Launois and Louis 1995). Even though spreading of TH2 
responses during early phases of L. major-infection is well established (Launois and 
Louis 1997, Stetson and Locksley 2002, Julia and Glaichenhaus 1996), the trigger 
leading to TH2-differentiation remains unclear. In addition, an important body of 
evidence suggests that in vivo TH2 responses primarily rely on the functional 
phenotype of the DC priming naïve TH cells (Moser and Murphy 2000, Langenkamp 
and Sallusto 2000, Stetson and Locksley 2002, Liu and Gilliet 2001, Kalinski and 
Kapsenberg 1999). In terms of DCs orchestrate the optimal balance in the 
development of the different types of TH cells (De Heusch and Moser 2004, De Jong 
and Kapsenberg 2005). These data now provide experimental prove to the concept 
that T cell differentiation is not only directed by DC and IL-4 producing NK T cells, but 
also directly by T-T-cell interactions. Even though unprimed TH2 memory cells have a 
defect to home spontaneously into lymph nodes (Iezzi and Lanzavecchia 2001), TH2 
cells enrich in paracortical lymph node areas with the same dynamics as naïve T 
cells, if attracted by specific peptide dissolved in CFA (Stoll and Germain 2002, Miller 
and Cahalan 2002). 
Previous data showing that IL-4 paradoxically primes DC to mature toward a TH1-
inducing phenotype of Dendritic cells (DC1) and that IL-4 induces TH2 maturation 
exclusively if present during the period of T cell priming (Biedermann and Rocken 
2001). Thus, it is likely that, in the system described here, TH2 cell-derived IL-4 did 
not induce DC2 but induced TH2-differentiation in HA-TCR cells through T-T-cell 
interactions. In agreement with this interpretation we found that deviation of CFA-
stimulated HA-TCR cells was strictly dependent on TH2 cell-derived IL-4, the strict co-
localization of naïve and TH2 cells and the requirement on the simultaneous 
activation of naïve and TH2 memory cells. Thus, the simple presence of TH2 memory 
cells did not affect CFA-driven TH1 development of HA-TCR cells. This is 
fundamentally different from DC-priming through CD40-CD40L-interactions, where 
activated TH cells modify the functional phenotype of DC in a way that they prime 
cytotoxic T cell responses more efficiently during subsequent interactions with naïve 
CD8+ T cells. 
The data reported here thus provide a solid explanation that TH1 and TH2 responses 
can normally co-exist even in individuals with multiple TH2 responses, such as in 
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patients with allergic asthma or allergic rhinitis. These individuals develop TH2-
responses to environmental aero-allergens that tend to spread to multiple epitopes 
(Prescott 1999, Kulig 1999), while they raise normal TH1-resposes against viruses, as 
long as these viruses do not infect the airways. Even though it is generally believed 
that TH2-development to multiple aero-allergens is genetically determined and TH2-
responses to aero-allergens start with only a single or a small spectrum of T cell 
epitopes. As these individuals are concomitantly exposed to multiple aero-allergens, 
TH2 cell-derived IL-4 may induce spreading of TH2 responses in lung-draining lymph 
nodes. This may also explain that silencing of TH2-responses to as little as 2-3 
leading aero-allergens significantly improves allergic rhinitis and why these 
individuals may raise normal TH1-responses if antigens are presented in lymph nodes 
draining regions distant from lung (Biedermann and Rocken 1999). 
The differentiation of naïve T cells either into TH1 or TH2 effector cells in vivo has also 
essential implications in specific tumor therapy. In cancer immunotherapy many 
vaccine strategies aim to stimulate the TH response specific for a tumor antigen. 
Furthermore early clinical trials have shown that modulating the immune system with 
tumor-specific TH1 and TH2 cells can result in significant levels of antigen-specific TH 
cells and cytotoxic T cells generating long lasting tumor immunity (Nishimura and 
Otha 1999, Hung and Levitsky 1998, Disis and Knutson 2004). Recent studies 
underlined that in vivo allosensitation during immunotherapy generates TH1 or TH2 
populations with differential in vivo capacity for expansion to alloantigen, resulting in 
differential graft-versus-tumor effects and graft-versus-host diseases (Jung and 
Fowler 2003). 
Thus, treatment with IL-4 is capable of inducing TH2 responses and to treat 
inflammatory autoimmune disease or contact-hypersensitivity in rodents (Racke and 
Rocken 1994, Biedermann and Rocken 2001) and psoriasis, a TH1-associated 
autoimmune disease in humans (Ghoreschi and Rocken 2003) using a cytokine-
based therapy that is currently based on systemic application of IL-4. This indicates 
that, in the future, a T cell cytokine such as IL-4 should be vectored either into 
clusters by in vitro-primed T cells (Gross and Kosmatopoulos 2004) or by means of 
gene transfer into Dendritic cells (Yamazaki and Steinman 2003) or into specific T 
cells (Biedermann and Carballido 2004). 
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